𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999–2004

✍ Scribed by Carol A. Parise; Katrina R. Bauer; Monica M. Brown; Vincent Caggiano

Book ID
109079900
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
238 KB
Volume
15
Category
Article
ISSN
1075-122X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of human epidermal growth facto
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004
✍ Monica Brown; Alex Tsodikov; Katrina R. Bauer; Carol A. Parise; Vincent Caggiano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract ## BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high‐grade histology, aggressive clinical behavior, and poor survival. It has been

Descriptive analysis of estrogen recepto
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype : A population-based study from the California cancer Registry
✍ Katrina R. Bauer; Monica Brown; Rosemary D. Cress; Carol A. Parise; Vincent Cagg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## BACKGROUND. Tumor markers are becoming increasingly important in breast cancer research because of their impact on prognosis, treatment, and survival, and because of their relation to breast cancer subtypes. The triple‐negative phenotype is important because of its relation to the b